We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

关于CoagClinic™ Self-Test Portal

Anticoag患者可记录/从任何地方跟踪他们的INR - 限制

Please Note: You’ll need prior authorization provided by a clinical service before you use this portal. Please contact us at 1.800.504.4032 for more details on how you can test your INR at home!

Optimize your anticoagulation care. Submit your INR results and other treatment-related information directly to the CoagClinic portal, where it can be reviewed by your clinician or physician. This portal allows you to record an INR result anytime from anywhere for review by a healthcare professional during your clinic’s hours of operation.

Features:

• Secure patient login with unique ID

• Record single or multiple INR results

• Answer questions related to your therapy (if provided by your clinic)

• View dosing information (if provided by your clinic)

• Track your progress via a graphic chart

• View your complete self-test history

• Send comments to your clinic

• Acelis Connected Health patients can also order new supplies

• Patients who receive a next-test date have the option to auto-create reminders and calendar items (if provided by your clinic)

Advantages:

• INR test results submitted directly to your physician or clinic in real time

• Secure data transmission and storage

• Results data reviewed and managed by clinicians based on physician-selected settings

• Software developed under supervision of a medical doctor

• Personal identifiable information will not be sold or otherwise marketed to third parties

最新版本2.0.0更新日志

Last updated on 2019年02月07日

We are now Acelis Connected Health!!

翻译中...

更多应用信息

最新版本

请求 CoagClinic™ Self-Test Portal 更新 2.0.0

上传者

Monky D Lofy

系统要求

Android 4.0+

更多

CoagClinic™ Self-Test Portal 屏幕截图

语言
订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
订阅成功!
您已订阅APKPure。
订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
成功!
您已订阅我们的邮件通知。